#hospital acquired infections testing kits market research

[omkarpatel]

Legionella Testing Market is Estimated to Witness High Growth Owing to Increasing Demand for Water Testing Services

Legionella testing refers to testing techniques that are used for the detection of Legionella bacteria, which causes Legionnaires' disease, a type of pneumonia. Legionella testing helps detect the presence of the bacteria in water systems like cooling towers, showers, fountains, hot tubs, and others. The increasing cases of Legionnaires' disease across the globe has raised awareness regarding regular monitoring and disinfection of water systems, driving the demand for legionella testing services. Furthermore, regulations regarding water safety and management in several countries mandate routine legionella testing of large cooling towers and complex plumbing systems.

The global legionella testing market is estimated to be valued at US$ 1,864.07 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity The opportunity of increasing demand for water testing services is driving the growth of the legionella testing market. With growing awareness regarding waterborne diseases and safety, many commercial facilities and industries are focusing on routine testing of their water systems for early detection of bacterial growth. Legionella testing helps detect Legionella contamination at an early stage and thus prevent potential outbreaks. The regulatory mandates in several regions regarding water quality monitoring have further boosted the adoption of legionella testing services among utilities, hotels, hospitals and other high-risk sectors. The market players are expected to gain significant opportunities by offering customized and portable testing kits and services for on-site legionella detection. Porter's Analysis Threat of new entrants: Low economies of scale in research and development pose barriers for new companies. Regulations for product approval are strict. Bargaining power of buyers: Large healthcare providers and government organizations can negotiate lower prices due to their high purchase volumes. Bargaining power of suppliers: Suppliers of key materials and technologies have some bargaining power as vendors depend on specialized components and technologies from few sources. Threat of new substitutes: Technological advancement brings new alternative testing methods but existing solutions are entrenched in workflows. Competitive rivalry: Intense competition among global companies to gain market share through product innovation and strategic mergers. SWOT Analysis Strengths: Growing incidence of hospital acquired infections drives demand. Advanced technologies enable more accurate and rapid testing. Weaknesses: High cost oftests limits widespread adoption. Shortage of skilled professionals hampers market growth. Opportunities: Expanding healthcare infrastructure in developing nations creates new opportunities. Point of care tests allow for decentralized testing. Threats: Stringent regulations raise compliance costs. Reimbursement policies impact pricing and purchasing decisions. Key Takeaways The global Legionella Testing Market is expected to witness high growth. Regional analysis: North America currently accounts for the largest share of the global Legionella Testing market led by developed healthcare systems and favorable reimbursement policies in the US and Canada. However, Asia Pacific is poised to grow at the highest CAGR during the forecast period with increasing healthcare spending by governments and demand for advanced testing technologies to cope with rising disease incidence. Countries like China and India will drive significant market opportunities. Key players: Key players operating in the Legionella Testing market are Boston Scientific Corporation, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Medtronic Plc., Novo Nordisk A/S, SERAG-WIESSNER GmbH & Co., Smithâ€TMs Medical, Terumo Corporation, Stryker Corporation, and NIPRO Medical Corporation. These companies have well established sales and distribution networks globally to cater to the growing testing needs. They are focusing on new product launches through R&D investments to consolidate their market position.

[adityarana1687-blog]

Molecular Diagnostics Market Expected To Achieve Lucrative Growth By 2030

The global molecular diagnostics market size is expected to reach USD 31.9 billion by 2030, and is expected to decline at a CAGR of -1.6% from 2022 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

Request a free sample copy or view report summary: Molecular Diagnostics Market Report

Molecular Diagnostics Market Report Highlights

Reagents dominated the overall market majorly driven by the high usage rate of reagents due to the COVID-19 pandemic

PCR technology accounted for a revenue share of 64.6% in 2021. The increased use of PCR for the diagnosis of COVID-19 and other infectious diseases is one of the major reasons for its dominance

Self-testing or OTC segment is anticipated to be the fastest-growing segment, over the forecast period, as it facilitates early diagnosis and constant patient monitoring. The launch of COVID-19 molecular self-tests is also expected to boost the growth of this segment.

North America commanded the highest revenue share in 2021, driven by a high disease prevalence, proactive government measures, high testing rate for COVID-19, technological advancements, and improvements in healthcare infrastructure.

Molecular Diagnostics Market Segmentation

For this report, Grand View Research has segmented the global molecular diagnostics market based on product, test location, technology, application, and region:

Product Outlook (Revenue, USD Million, 2017 - 2030)

Instruments

Reagents

Others

Test Location Outlook (Revenue, USD Million, 2017 - 2030)

Point-of-Care

Self-test or Over the Counter

Central Laboratories

Technology Outlook (Revenue, USD Million, 2017 - 2030)

Polymerase chain reaction (PCR)

PCR, by Type

Multiplex PCR

Other PCR

PCR, by Product

Instruments

Reagents

Others

In Situ Hybridization (ISH)

Instruments

Reagents

Others

Isothermal Nucleic Acid Amplification Technology (INAAT)

Instruments

Reagents

Others

Chips and Microarrays

Instruments

Reagents

Others

Mass Spectrometry

Instruments

Reagents

Others

Sequencing

Instruments

Reagents

Others

Transcription Mediated Amplification (TMA)

Instruments

Reagents

Others

Others

Instruments

Reagents

Others

Application Outlook (Revenue, USD Million, 2017 - 2030)

Oncology

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Kidney Cancer

Liver Cancer

Blood Cancer

Lung Cancer

Other Cancer

Pharmacogenomics

Infectious Diseases

Methicillin-resistant Staphylococcus Aureus (MRSA)

Clostridium Difficile

Vancomycin-resistant Enterococci (VRE)

Carbapenem-resistant Bacteria

Flu

Respiratory Syncytial Virus (RSV)

Candida

Tuberculosis and Drug-resistant TBA

Meningitis

Gastrointestinal Panel Testing

Chlamydia

Gonorrhea

HIV

Hepatitis C

Hepatitis B

Other Infectious Disease

Genetic Testing

Newborn Screening

Predictive and Presymptomatic Testing

Other Genetic Testing

Neurological Disease

Cardiovascular Disease

Microbiology

Others

Regional Outlook (Revenue, USD Million, 2017 - 2030)

North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Belgium

Switzerland

Netherlands

Poland

Austria

Greece

Sweden

Turkey

Finland

Asia Pacific

Japan

China

India

Sri Lanka

Malaysia

Australia

New Zealand

Thailand

Vietnam

Singapore

Latin America

Brazil

Mexico

Chile

Peru

Colombia

Argentina

Middle East & Africa

South Africa

Saudi Arabia

Jordan

UAE

Qatar

Nigeria

Egypt

[healthcare-domain]

Sepsis Diagnostics Market Growth Drivers & Opportunities | MarketsandMarkets

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for sepsis diagnostic research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness.

Sepsis is a very difficult condition to diagnose and the risk of mortality increases by 7.6% with a delay of even 1 minute in antibiotic administration in septic shock patients with hypertension. Thus, increasing the need for the rapid diagnosis of sepsis to reduce the delay of antibiotic therapy among patients with sepsis. Many sepsis diagnostic manufacturers are expanding their product offering in point of care technology rapidly detecting the sepsis, reducing the overall turnaround time of diagnosis.

The BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments manufactured by BD Company (US) is an automated microbial detection system offering a rapid diagnosis of sepsis in the turnaround time of three hours.

According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments, Software), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), End User (Hospital, Pathology Lab) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9% from 2021 to 2026.

Browse in-depth TOC on "Sepsis Diagnostics Market" 201 – Tables 47 – Figures 236 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the rising prevalence of sepsis across the globe. Factors such as the increasing geriatric population, a growing number of surgical procedures, a high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are expected to drive market growth.

The COVID-19 pandemic had a positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales.

The shortage of skilled professionals is a major concern worldwide; only 50% of patients with severe sepsis transported by the EMS system have a paramedic. The lack of trained paramedics affects each phase of patient caremdash;sepsis awareness, screening patients for the presence of sepsis, and making an appropriate.

The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155

Based on technology, the biomarkers segment is expected to register the highest growth rate during the forecast period

Based on technology, the global sepsis diagnostics market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to various advantages offered by this technique in the diagnosis of sepsis and the growing need for early disease diagnosis.

North America accounted for the largest share of the sepsis diagnostics market

Geographically, the sepsis diagnostic market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to account for the largest share of the market. This can be attributed to the growing prevalence of sepsis, increasing incidence of hospital-acquired infections, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

[globalmarketsresearchreports]

Global Hospital Acquired Infections Testing Kits Market Competitive Strategies and Forecasts to 2031

The Hospital Acquired Infections Testing Kits Global Market Report 2021-31 by The Business Research Company describes and explains the global hospital acquired infections testing kits market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Hospital Acquired Infections Testing Kits Global Market Report 2022 covers hospital acquired infections testing kits market drivers, hospital acquired infections testing kits market trends, hospital acquired infections testing kits market segments, hospital acquired infections testing kits market growth rate, hospital acquired infections testing kits market major players, and hospital acquired infections testing kits market size.

View Complete Report:

The hospital acquired infections testing kits market report provides in-depth analysis of the impact of COVID-19 on the global hospital acquired infections testing kits industry along with revised market numbers due to the effects of the coronavirus and the expected hospital acquired infections testing kits market growth numbers for 2022-2031.

The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The global hospital acquired infection testing kit market share is expected to grow to $1.78 billion in 2026 at a CAGR of 8.8%.

Request Report Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Hospital Acquired Infections Testing Kits Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the hospital acquired infections testing kits market segments- 1) By Product: Instrument and Reagents, Consumables

2) By Test Type: Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Others

3) By Application: Drug-Resistance Testing, Disease Testing

4) By Pathogen Type: Viral, Bacterial, Fungal

5) By Method of Treatment: Sterilization, Chemical, Radiation

Table Of Contents

1. Executive Summary

2. Hospital Acquired Infections Testing Kits Market Characteristics

3. Hospital Acquired Infections Testing Kits Market Trends And Strategies

4. Impact Of COVID-19 On Hospital Acquired Infections Testing Kits

5. Hospital Acquired Infections Testing Kits Market Size And Growth

.

.

26. Africa Hospital Acquired Infections Testing Kits Market

27. Hospital Acquired Infections Testing Kits Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Hospital Acquired Infections Testing Kits Market

29. Hospital Acquired Infections Testing Kits Market Future Outlook and Potential Analysis

30. Appendix

About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.  

Contact Information:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Find us on

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany/

Blog: http://blog.tbrc.info/

[healthcare-market]

Mycoplasma Diagnostics Market Boosting the Healthcare Industry Worldwide

The global mycoplasma infections diagnostics market is consolidated to a large extent with the leading five vendors jointly accounting for 68.0 % of the global market in 2016, notes Transparency Market Research (TMR). The leading companies are Lonza Group, Agilent Technologies, Merck KGaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific, Inc. The global landscape is also markedly competitive and top vendors are focusing on entering into mergers and acquisitions and making geographic expansion, in order to consolidate their positions.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1677

However, the growing number of mergers, acquisitions, and collaborations in the global market will bring down the degree of competition to some extent, as the shares will be spread across few prominent shares in the years to come. TMR observes that a number of players are engaged in accelerating the development of technologically-advanced diagnostic kits with enhanced efficacy.

The global mycoplasma diagnostics market is projected to rise at a strong CAGR of 10.6% in between the forecast period of 2016 and 2024. Rising at this pace, the global market will rise from a worth of US$602.0 million in 2016 to reach a worth US$1.35 billion by 2024 end.

Request for Analysis of COVID19 Impact on Mycoplasma Diagnostics Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1677

The key technologies used in the diagnosis of mycoplasma infections are polymerase chain reaction (PCR), immunoassay, microbial culture techniques, and DNA staining. Of all the key segments, PCR method dominated the market in 2016 and its demand is projected to rise substantially through 2024. The popularity is attributed to increasing incidence of hospital-acquired and healthcare-associated infections world over.

Regionally, North America led the global market with its dominant share in 2016. The extensive uptake of diagnostics for mycoplasma pneumoniae infections is attributed to the large number of laboratories present across the region and the heightened awareness among patient populations.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1677

High Morbidity and Mortality of Respiratory Tract Infections bolster Demand for Mycoplasma Infections Diagnostics

The global market for mycoplasma infections diagnostics is driven primarily by the growing prevalence of respiratory tract infections that can lead to incidence of lung cancer, tuberculosis, and obstructive pulmonary diseases. In addition, the concomitant rise in the associated mortality in worldwide populations is bolstering the demand for mycoplasma diagnostics. The rising demand for laboratory investigation for the diagnosis of mycoplasma pneumoniae pathogens is propelling the growth of the market.

The rapid rise in geriatric population, especially in developing and developed nations, who are increasingly prone to respiratory tract infections is a crucial factor catalyzing the growth of the market. The rising awareness of the multiple etiologies that mycoplasma infections harbors among worldwide communities has accentuated the need for direct pathogen detection. Furthermore, the rising healthcare infrastructure spending by public and private players in developed regions is likely to help in the rapid expansion of the global market.

Buy now Mycoplasma Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1677&ltype=S

Lack of Reliability of Laboratory Tests and High Cost hindering Widespread Uptake

Despite the rapidly rising demand for mycoplasma diagnostics, few factors are hindering the uptake.  The high cost of the devices and consumables used in the testing kits for the infections is one of them. The lack of reliability of these tests in correcting determining microbiological etiology for mycoplasma pneumoniae also acts as a bottleneck in the growth of the market. Furthermore, the market is suffering notable setbacks in advanced nations of North America and Europe owing to stringent regulator norms for the approval of diagnostics or laboratory testing methods.

Nevertheless, the market is likely to witness exciting avenues arising out of substantial advancements in PCR-related methods and molecular biology technologies in recent years. Advancement in diagnostic techniques in recent years has consistently upped their effectiveness, which has helped healthcare providers and caregivers in ascertaining the severity of the diseases before it turns into an epidemic.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Mycoplasma Diagnostics Market (Product - Kits & Reagents, Instruments, and Software & Services; Technology - PCR, Immunoassay (ELISA and RIA), DNA Staining, and Microbial Culture Techniques; End User - Hospitals, Diagnostic Laboratories, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016–2024.”

More Trending Reports by Transparency Market Research:

https://www.prnewswire.co.uk/news-releases/single-use-cystoscope-market-to-reach-valuation-of-us-150-mn-by-2031-growing-acceptance-of-patient-ready-instruments-in-urology-to-bolster-demand-tmr-study-818277477.html

https://www.prnewswire.co.uk/news-releases/cell-amp-tissue-preservation-market-to-reach-us-10-04-bn-by-2031-increase-in-demand-for-regenerative-therapies-to-trigger-growth-of-the-market-says-tmr-882063013.html

https://www.prnewswire.co.uk/news-releases/fibrinogen-concentrates-market-to-reach-valuation-of-us-700-mn-by-2031-high-volume-clinical-use-in-coagulation-applications-bolsters-market-growth-tmr-873649318.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[researchindustry]

Infectious Testing Market is Booming Market to Grow at Healthy CAGR forecast by 2028

Infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body.

Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Segmentation: Global Infectious Testing Market

·         By Product & Service(Assays, Kits, & Reagents , Instruments , Services & Software)

·         By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)

·         By Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Disease)

·         By End User(Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users )

Competitive Analysis: Global Infectious Testing Market

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others

Market Drivers

·         Increasing prevalence of infectious diseases is a driver for this market

·         Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth

·         High investment in R&D activities from government and personal organizations is boosting the market growth

·         Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Market Restraints

·         Increasing prices of healthcare is restraining the market growth

·         Complicated administrative structure hampers the growth of the market

·         Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Reasons to Purchase this Report

·         Current and future of global infectious testing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Infrared Spectroscopy Market

Intraoperative Imaging Market

[marketnewsreport]

Infectious Testing Market Shows Strong Growth with Leading Players

Infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body.

Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Segmentation: Global Infectious Testing Market

·         By Product & Service(Assays, Kits, & Reagents , Instruments , Services & Software)

·         By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)

·         By Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Disease)

·         By End User(Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users )

Competitive Analysis: Global Infectious Testing Market

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others

Market Drivers

·         Increasing prevalence of infectious diseases is a driver for this market

·         Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth

·         High investment in R&D activities from government and personal organizations is boosting the market growth

·         Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Market Restraints

·         Increasing prices of healthcare is restraining the market growth

·         Complicated administrative structure hampers the growth of the market

·         Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Reasons to Purchase this Report

·         Current and future of global infectious testing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Infrared Spectroscopy Market

Intraoperative Imaging Market

[healthcare-domain]

Rising Growth of Sepsis Diagnostics Market

The COVID-19 pandemic had a moderately positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, & assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales.

The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections. 

The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. In the US, the incidence of sepsis among hospitalized patients is rising by 8.7% per year.

It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years. 

The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests, priced as low as ~USD 28–35. Companies focus on developing automated diagnostic devices based on advanced technologies, such as molecular diagnostics, on detecting sepsis but due to limited budgets, government hospitals (especially in emerging nations) and academic research laboratories cannot afford such systems. 

For More Info, Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155   

[236 Pages Report] The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for sepsis diagnostic research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness. 

The sepsis diagnostics market, by product, the market is segmented into blood culture media, assays & reagent kits, instruments, and software. The blood culture media segment accounted for the largest share of market during the forecast period. This share can be attributed to the growing utilization of blood culture media by hospitals & pathology laboratories for the diagnosis of sepsis coupled with an increase in the availability of blood culture media in the market.

The prominent players operating in the global sepsis diagnostics market include bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US), Abbott Laboratories (US), Immunexpress (Australia), Axis-Shield Diagnostics (UK), Quidel Corporation (US), Siemens Healthineers (Germany), EKF Diagnostics (UK), Seegene Inc., (South Korea), Boditech Med (South Korea), Alifax S.r.l. (Italy), AdvanDx  (US), (US), Immunexpress (Australia), and Axis-Shield Diagnostics (UK).

[marketsresearchdbmr]

Infectious Testing Market Shows Strong Growth with Leading Players

Infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body.

Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Segmentation: Global Infectious Testing Market

·         By Product & Service(Assays, Kits, & Reagents , Instruments , Services & Software)

·         By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)

·         By Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Disease)

·         By End User(Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users )

Competitive Analysis: Global Infectious Testing Market

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others

Market Drivers

·         Increasing prevalence of infectious diseases is a driver for this market

·         Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth

·         High investment in R&D activities from government and personal organizations is boosting the market growth

·         Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Market Restraints

·         Increasing prices of healthcare is restraining the market growth

·         Complicated administrative structure hampers the growth of the market

·         Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Reasons to Purchase this Report

·         Current and future of global infectious testing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Infrared Spectroscopy Market

Intraoperative Imaging Market

[techsciresearch]

Outpatient Hospital Services Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Increasing concerns for patient care is driving the growth in Global Outpatient Hospital Services Market in the forecast period, 2022-2026.

According to TechSci Research report, “Global Outpatient Hospital Services Market By Services (Treatment Services, Diagnostic Tests, Minor Surgical Procedures, Others) By Type (Emergency Department, Urgent Care Centers, Primary Care Clinics, Specialized Outpatient Clinics, Others) By Region, Competition Forecast & Opportunities, 2026”, the global outpatient hospital services market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of surge in the demand for better and efficient healthcare services along with the demand from the patient care sector.

Large hospitals and healthcare centers accommodate a large population. Patients in the need of round the clock care are often rendered unattended due to lack of staff or mismanagement. Outpatient hospital services aids the situation by providing inexpensive patient care at affordable rates. Rising number of patients suffering from chronic diseases like cancer, cardiovascular diseases, neural degenerations, Alzheimer’s disease, etc. are further substantiating the growth of the global outpatient hospital services market in the upcoming five years.

Outpatient hospital services are the healthcare services that are provided to the patients often suffering from chronic or lifestyle diseases. Some of the outpatient service also includes surgical operations that are carried in clinics, and specialty hospitals or healthcare centers and the post-op procedures are carried out in outpatient facilities and often home care settlement.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on " Global Outpatient hospital services Market"

https://www.techsciresearch.com/report/outpatient-hospital-services-market/7732.html

The global outpatient hospital services market segmentation based on services, type, competitional landscape, and regional distribution. Based on type, the market is further differentiated into emergency department, urgent care centers, primary care clinics, specialized outpatient clinics, and others. Primary care clinics are anticipated to hold the largest revenue shares of the market and assert its dominance on the market segment on the account of rising concerns for the in expensive hospital bills even for basic healthcare facility.

Primary care clinics are the health care service providers that provide the services like first point of contact in healthcare systems. This includes general practice, community pharmacy, dental, and optometry services. Emergency department is expected to register fastest growing CAGR growth in the next five years owing to the rapid demand for the emergency facilities along with the rising instances of the emergency situation as in road accidents, sudden cardiovascular threats, or other accidental instances where the patient requires immediate attention. Specialized outpatient clinics are also expected to register significant growth on the account of increasing number of patient suffering from lifestyle and chronic diseases.

Based on services, the market is further bifurcated into treatment services, diagnostic tests, minor surgical procedures, and others. The diagnostic tests are expected to hold the largest revenue shares of the market and dominate the segment in the next five years on the account of increasing number of diagnostic centers and advancement of technologies that support the early and effective diagnosis of various diseases. Rapidly increasing number of blood tests, urine tests, thyroid tests, and glucose tests are further substantiating the growth of the global outpatient hospital services market in the upcoming five years.

Treatment services are expected to register significant growth in the future five years on the account of the rapidly increasing demands for the efficient and effective treatment in the outpatient hospitals. Advanced technologies have made it possible for the patients to avail healthcare services in specialty hospitals and clinics as mobile medical devices are affordable and accessible for them. These factors are actively supporting the growth of the global outpatient hospital service market in the next five years.

Holding the major shares of the global outpatient hospital services market are Apollo Hospitals Enterprise Limited, Max Healthcare Institute Limited, Fortis Healthcare Limited, Aster DM Healthcare Limited, HCA Healthcare, Inc., Community Health Systems, Inc., Tenet Healthcare Corporation, ORPEA Group, Netcare Limited, Spire Healthcare Group plc, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments.

The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through outpatient hospital services. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7732

Customers can also request for 10% free customization on this report.

“North America supports the most promising and most established healthcare industry. The region is expected to dominate the global market for outpatient hospital services on the account of rapidly increasing market players in the large economies like United States and Canada. Rapidly evolving healthcare infrastructure and advancing technology is supporting the esteemed growth of the global outpatient hospital services. The new market players must focus on the extended research and technological advancements for the future brad establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Outpatient Hospital Services Market By Services (Treatment Services, Diagnostic Tests, Minor Surgical Procedures, Others) By Type (Emergency Department, Urgent Care Centers, Primary Care Clinics, Specialized Outpatient Clinics, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global outpatient hospital services and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global outpatient hospital services market.

Browse Related Reports:

Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html

Global Biotechnology Market By Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others) By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Others) By End User (Research Institutes & Laboratories, Academic Institutions, Biotechnology & Pharmaceutical Companies, Others), By Region, Company Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/biotechnology-market/7573.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[techscimarketresearch]

Outpatient Hospital Services Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Increasing concerns for patient care is driving the growth in Global Outpatient Hospital Services Market in the forecast period, 2022-2026.

According to TechSci Research report, “Global Outpatient Hospital Services Market By Services (Treatment Services, Diagnostic Tests, Minor Surgical Procedures, Others) By Type (Emergency Department, Urgent Care Centers, Primary Care Clinics, Specialized Outpatient Clinics, Others) By Region, Competition Forecast & Opportunities, 2026”, the global outpatient hospital services market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of surge in the demand for better and efficient healthcare services along with the demand from the patient care sector.

Large hospitals and healthcare centers accommodate a large population. Patients in the need of round the clock care are often rendered unattended due to lack of staff or mismanagement. Outpatient hospital services aids the situation by providing inexpensive patient care at affordable rates. Rising number of patients suffering from chronic diseases like cancer, cardiovascular diseases, neural degenerations, Alzheimer’s disease, etc. are further substantiating the growth of the global outpatient hospital services market in the upcoming five years.

Outpatient hospital services are the healthcare services that are provided to the patients often suffering from chronic or lifestyle diseases. Some of the outpatient service also includes surgical operations that are carried in clinics, and specialty hospitals or healthcare centers and the post-op procedures are carried out in outpatient facilities and often home care settlement.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on " Global Outpatient hospital services Market"

https://www.techsciresearch.com/report/outpatient-hospital-services-market/7732.html

The global outpatient hospital services market segmentation based on services, type, competitional landscape, and regional distribution. Based on type, the market is further differentiated into emergency department, urgent care centers, primary care clinics, specialized outpatient clinics, and others. Primary care clinics are anticipated to hold the largest revenue shares of the market and assert its dominance on the market segment on the account of rising concerns for the in expensive hospital bills even for basic healthcare facility.

Primary care clinics are the health care service providers that provide the services like first point of contact in healthcare systems. This includes general practice, community pharmacy, dental, and optometry services. Emergency department is expected to register fastest growing CAGR growth in the next five years owing to the rapid demand for the emergency facilities along with the rising instances of the emergency situation as in road accidents, sudden cardiovascular threats, or other accidental instances where the patient requires immediate attention. Specialized outpatient clinics are also expected to register significant growth on the account of increasing number of patient suffering from lifestyle and chronic diseases.

Based on services, the market is further bifurcated into treatment services, diagnostic tests, minor surgical procedures, and others. The diagnostic tests are expected to hold the largest revenue shares of the market and dominate the segment in the next five years on the account of increasing number of diagnostic centers and advancement of technologies that support the early and effective diagnosis of various diseases. Rapidly increasing number of blood tests, urine tests, thyroid tests, and glucose tests are further substantiating the growth of the global outpatient hospital services market in the upcoming five years.

Treatment services are expected to register significant growth in the future five years on the account of the rapidly increasing demands for the efficient and effective treatment in the outpatient hospitals. Advanced technologies have made it possible for the patients to avail healthcare services in specialty hospitals and clinics as mobile medical devices are affordable and accessible for them. These factors are actively supporting the growth of the global outpatient hospital service market in the next five years.

Holding the major shares of the global outpatient hospital services market are Apollo Hospitals Enterprise Limited, Max Healthcare Institute Limited, Fortis Healthcare Limited, Aster DM Healthcare Limited, HCA Healthcare, Inc., Community Health Systems, Inc., Tenet Healthcare Corporation, ORPEA Group, Netcare Limited, Spire Healthcare Group plc, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments.

The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through outpatient hospital services. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7732

Customers can also request for 10% free customization on this report.

“North America supports the most promising and most established healthcare industry. The region is expected to dominate the global market for outpatient hospital services on the account of rapidly increasing market players in the large economies like United States and Canada. Rapidly evolving healthcare infrastructure and advancing technology is supporting the esteemed growth of the global outpatient hospital services. The new market players must focus on the extended research and technological advancements for the future brad establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Outpatient Hospital Services Market By Services (Treatment Services, Diagnostic Tests, Minor Surgical Procedures, Others) By Type (Emergency Department, Urgent Care Centers, Primary Care Clinics, Specialized Outpatient Clinics, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global outpatient hospital services and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global outpatient hospital services market.

Browse Related Reports:

Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html

Global Biotechnology Market By Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others) By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Others) By End User (Research Institutes & Laboratories, Academic Institutions, Biotechnology & Pharmaceutical Companies, Others), By Region, Company Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/biotechnology-market/7573.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[latestanalysis]

Global Molecular Diagnostics Market in India, 2020 - Growth Opportunities, Latest Governmernt Regulations, Key Players , Major Challenges, Region Analysis Report

Global Molecular Diagnostics Market was valued at USD 8.74 billion in 2019 which is expected to reach at USD 13.58 billion by 2027 at a CAGR 8.5%. Qualiket Research provide in depth analysis of global molecular diagnostics market with latest trends, and opportunities.

Molecular diagnostic technique is used to analyze and identify proteins or nucleic acids at a molecular level. This technique helps monitor and diagnose diseases as well as helpful to decide which therapy should be administered to patient. Also, this technique provides quantitative measurements which inform energy stage of care and management of health conditions.

Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Molecular-Diagnostics-Market/request-sample

Increase in prevalence of infectious diseases like COVId-19, influenza, HPV, HIV hepatitis, and Tuberculosis which is expected to boost the global molecular diagnostics market growth. Furthermore, increase in advancements in molecular diagnostics has facilitated detection of number of diseases and which will positively influence the market growth over the forecast period. Also, growing government and numerous organizations initiatives and findings for research and development in molecular diagnostics is projected to fuel the market growth during this forecast period. Moreover, increase in prevalence of hospital-acquired infections and infectious diseases are anticipated to raise the demand for molecular diagnostics market during this forecast timeline.

Delay in the approval of molecular diagnostic products and tests are the major concerns which are expected to hinder the global molecular diagnostic market growth. Regulatory requirements applied to molecular diagnostics are becoming stringent which may limit the market growth.

The demand for molecular diagnostics products and services will increase due to COVID-19 pandemic across the globe. Also, sharp rise in supportive regularity landscape for product development and its launch as well as rise in target patient population will fuel the global molecular diagnostic market growth.

Market Segmentation

The report have segmented global molecular diagnostics market according to the product and services such as Reagents & Kits, Instruments, and Software & Service, by technology such as Polymerase Chain Reaction (PCR), DNA Sequencing and NGS, Isothermal Nucleic Acid Amplification Technology, DNA Microarrays, In Situ Hybridization, and Others, by application such as Infectious Diseases, Oncology, Genetic Tests, and Others. Further, market is segmented into end user such as Hospital and Academics Laboratories, Reference Laboratories, and Others.

Get discount on this report @ https://qualiketresearch.com/request-sample/Molecular-Diagnostics-Market/ask-for-discount

Regional Analysis

On the basis region global molecular diagnostics market is segmented into five regions including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

The North America is hold largest market share in molecular diagnostics market across the globe over the forecast period. Due to rise in geriatric population and easy availability of advanced healthcare infrastructure in this region. The Europe is the second largest region in global molecular diagnostic market during this forecast timeline. The increase in investments and funds for R & D as well as increase in support from government for life science sector. In addition to that, Asia Pacific is fastest growing market due to developing economies such as India, China, and South Korea.

Market Key Players

Major Key players are listed in global molecular diagnostics market report including Abbott Laboratories, Qiagen, Illumina, Hologic, Grifols, Diasorin, Danaher Corporation, Biomérieux, Becton, Dickinson and Company,and Agilent Technologies

Key Features

· Reagents and kits held the largest market share in 2019 and which is also fastest growing product segment due to its high adoption in research and clinical settings.

· Infectious diseases is also largest revenue generating factor as molecular diagnostics provide clinicians with better substitutes to diagnose various infectious pathogens, virus, and bacteria with accurate results.

· Qualiket Research report provide in depth analysis with latest market trends and key developments.

Browse Full Research Report @ https://qualiketresearch.com/reports-details/Molecular-Diagnostics-Market

[ojasdbmr]

Infectious Testing Market Research, Agency, Business Opportunities with New Players

Infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Segmentation: Global Infectious Testing Market

·         By Product & Service(Assays, Kits, & Reagents , Instruments , Services & Software)

·         By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)

·         By Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Disease)

·         By End User(Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users )

Competitive Analysis: Global Infectious Testing Market

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others

Market Drivers

·         Increasing prevalence of infectious diseases is a driver for this market

·         Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth

·         High investment in R&D activities from government and personal organizations is boosting the market growth

·         Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Market Restraints

·         Increasing prices of healthcare is restraining the market growth

·         Complicated administrative structure hampers the growth of the market

·         Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Reasons to Purchase this Report

·         Current and future of global infectious testing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Infrared Spectroscopy Market

Intraoperative Imaging Market

[researchindustry]

Infectious Testing Market is Booming Market to Grow at Healthy CAGR forecast by 2028

Infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body.

Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Competitive Analysis: Global Infectious Testing Market

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Segmentation: Global Infectious Testing Market

·         By Product & Service(Assays, Kits, & Reagents , Instruments , Services & Software)

·         By Technology(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)

·         By Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other Infectious Disease)

·         By End User(Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users )

Key Market Competitors:

Few of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others

Market Drivers

·         Increasing prevalence of infectious diseases is a driver for this market

·         Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth

·         High investment in R&D activities from government and personal organizations is boosting the market growth

·         Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Market Restraints

·         Increasing prices of healthcare is restraining the market growth

·         Complicated administrative structure hampers the growth of the market

·         Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Reasons to Purchase this Report

·         Current and future of global infectious testing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Infrared Spectroscopy Market

Intraoperative Imaging Market

[fostermarketarch]

Future Scope Of Automated Antimicrobial Susceptibility Testing Market By Top Key Players

The global automated antimicrobial susceptibility testing market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). The objective of automated antimicrobial susceptibility testing is to diagnose possible drug resistance in ordinary pathogens and ensure the responsiveness of the drugs of choice for a specific infection. The most extensively used testing technique includes micro broth dilution, which is also known as rapid automated instrument methods that use economically marketed materials and equipment.

The execution of antimicrobial susceptibility testing by the clinical microbiology laboratory is crucial to authenticate susceptibility to selected empirical antimicrobial agents or to diagnose resistance in individual bacterial isolates. Increasing government ingenuity concerning the development of quality hospital infrastructure globally contributes to the growth of the automated antimicrobial susceptibility testing market.

Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/clinical-diagnostic/410/Pdf%20Brochure/

Competitive Landscape:

Key players in the global automated antimicrobial susceptibility testing market include  Alifax SpA,  Accelerate Diagnostics, Inc.,Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Creative Diagnostics, Bioanalyse Tibbi Malz. San. ve Tic. Ltd. Sti., HiMedia Laboratories, Liofilchem S.r.l.,  Merlin Diagnostica GmbH, Merck KGaA,Synbiosis, Thermo Fisher Scientific, Inc., and Zhuhai Dl Biotech Co., Ltd.

Various productive strategies have been adopted by the key market players to blossom their share and position in the market in the view to increase their revenue these approaches mainly includeshuge investment on R&D, product innovations, increasing investment in online sales channels and receiving approvals from government. For instance, in February 2017, Accelerate Diagnostics, Inc. (Accelerate) declared that the U.S. Food and Drug Administration had given approval to the de novo request to market the Accelerate Pheno system and Accelerate PhenoTest BC kit for recognition and antibiotic susceptibility testing of pathogens right from positive blood culture samples.

Market Dynamics:

Lately, the time has evidenced a significant movement towards personalized medicines and the development of new websites, which is surging the demand for automated antimicrobial susceptibility testing products and surging susceptibility to infectious disorders, which are estimated to widen the demand for automated antimicrobial susceptibility tests throughout the foresee future.

.  For instance, in December 2017, The U.S. Food and Drug Administration (FDA) released a new website focused on enhancing access to information that can assist healthcare professionals in deciding which drugs are most likely to work to treat bacterial or fungal infections.

. The website has been made under the efforts of 21st-century cures act, which has made it mandatory with the motive to combat increasing antimicrobial resistance by offering a central, convenient, accessible, and up-to-date repository for antimicrobial susceptibility interpretive criteria, also known as antimicrobial "breakpoints".

Request Customization of this Report @ https://www.fostermarketresearch.com/product/industry/clinical-diagnostic/410/Customization/

Market Taxonomy:

By Product Type

Automated Laboratory Instruments

Consumables

By Detection Method

Turbidimetric

Colorimetric

By Application

AntibacterialTuberculosis Sepsis

AntifungalAnti-parasitic Anti-viral

By End User

Diagnostic Laboratories and Hospitals

Pharmaceutical and Biotechnology Companies

Research and Academic Institutes

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

For More Information of this Report @ https://www.fostermarketresearch.com/4/Global%20Automated%20Antimicrobial%20Susceptibility%20Testing%20Market/

Benefits You Gain With Our Research Methodology:

Develop your Business strategies to refine the profits in near team.

Grow your Business profit ratio through our analytics report.

Acquire the valuable insights on different products, services and technology along with their obsolescence nature in the foreseen period.

Gain and upper hand on competition by having competitive financial, growth and economic data.

Identity future threats by our accurate forecasting strategies.

Obtain Go-To market strategy to increase your chances in the existing market.

Buy Now this Premium Report to Grow your Business @ https://www.fostermarketresearch.com/product/buy/clinical-diagnostic/410/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com